Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
about
Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsSafety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program.Liraglutide Therapy for Type 2 Diabetes: Overcoming Unmet NeedsComparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study.The role of incretin therapy at different stages of diabetes.Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy usersExenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes.Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protects H9c2 cells from apoptosis.Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*.
P2860
Q27010669-0C5EE42A-2E6E-468D-B226-9B5C3F39E3A0Q31066859-9423C547-8BC4-433C-ACEE-3CF9DFABCE21Q33664253-8FC05F88-1A26-44F9-918A-AD5DCDB4B451Q35679062-6EA75EA5-0470-471B-B4F9-E944352124C8Q35760288-D67D4AD5-A636-4B24-9CF3-7751AB3014A5Q37077942-D07C4F59-294F-47D9-973A-6AA893C348DBQ37639310-60CCE34C-3250-4C23-BCCB-309C16B3D372Q38083047-7336D4DE-3715-4E8F-AE91-657ABA1F8D4AQ39436443-0E618DF1-F81D-4F72-B364-8C77DCE0A756Q45376082-B43C3198-FFA3-4385-A663-093AA2D2DBAE
P2860
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@ast
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@en
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists.
@nl
type
label
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@ast
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@en
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists.
@nl
prefLabel
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@ast
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@en
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists.
@nl
P2860
P356
P1476
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
@en
P2860
P304
P356
10.1900/RDS.2009.6.247
P577
2009-12-30T00:00:00Z